Drug
Neurotropin
Neurotropin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_2
2
40%
Ph phase_3
3
60%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (40.0%)
Phase 33 (60.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
NCT07320950
completedphase_2
Neurotropin Treatment of Fibromyalgia
NCT00366535
terminatedphase_2
Neurotropin to Treat Chronic Neuropathic Pain
NCT00006289
completedphase_3
Analgecine for the Treatment of Neuropathic Pain
NCT02633618
completedphase_3
Analgecine for Treatment of Low Back Pain
NCT02168010
Clinical Trials (5)
Showing 5 of 5 trials
NCT07320950Phase 3
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
NCT00366535Phase 2
Neurotropin Treatment of Fibromyalgia
NCT00006289Phase 2
Neurotropin to Treat Chronic Neuropathic Pain
NCT02633618Phase 3
Analgecine for the Treatment of Neuropathic Pain
NCT02168010Phase 3
Analgecine for Treatment of Low Back Pain
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5